Global forests are a rich source of antiviral, antibacterial, and antifungal bioactive compounds with underutilized commercial opportunities. Many of the potential candidate compounds or groups of compounds have already been identified and studied to some extent on R&D level, but there is still a vast amount of untapped business potential in finding new more potent compounds, and developing new innovations based on already accumulated knowledge. The forest industry can offer solutions by producing antiviral and antimicrobial bioactive compounds that can be used as part of the treatment against the viral infection.



Russia is having one of the world’s most important untapped wide boreal forest resources and we can see a change in their investment environment. How will the resources be utilized?